메뉴 건너뛰기




Volumn 3, Issue 2, 2004, Pages 153-160

Delineating somatostatin's neuronal actions

Author keywords

3 , 5 cyclic adenosine monophosphate; Alzheimer's disease; Central nervous system; Epilepsy; G proteins; Huntington's disease; Multiple sclerosis; Neuropathy; Nociception; Non peptidyl agonists; Parkinson's disease; Somatostatin; Somatostatin receptors

Indexed keywords

BRADYKININ; CHOLINE ACETYLTRANSFERASE; CORTICOTROPIN; DOPAMINE; GROWTH HORMONE; LIGAND; MEMBRANE PROTEIN; MEMBRANE RECEPTOR; OCTREOTIDE; PASIREOTIDE; PROSTAGLANDIN; PROTEIN INHIBITOR; PROTEINASE; RECEPTOR PROTEIN; RECEPTOR SUBTYPE; SEROTONIN; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; SUBSTANCE P; UNCLASSIFIED DRUG; VAPREOTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE; SOMATOSTATIN;

EID: 2642540929     PISSN: 1568007X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568007043482534     Document Type: Review
Times cited : (21)

References (129)
  • 48
    • 0031010856 scopus 로고    scopus 로고
    • B.E. Beckwith, A. Saria, B.M. Chronall, C.A. Sandman, F.L. Strand, Eds., The New York Academy of Sciences: New York
    • Bissette G. In Neuropeptides in Development and Aging, B.E. Beckwith, A. Saria, B.M. Chronall, C.A. Sandman, F.L. Strand, Eds., The New York Academy of Sciences: New York, 1997, pp 17-29.
    • (1997) Neuropeptides in Development and Aging , pp. 17-29
    • Bissette, G.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.